Greece: Infringement by equivalence affirmed

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Greece: Infringement by equivalence affirmed

While the doctrine of equivalents exists in theory in most Greek legal textbooks, judgments applying this theory in practice are scarce in Greece. A recently issued judgment by the Athens Court of First Instance in preliminary injunction proceedings is an important addition to this rather small number of judgments.

The dispute at issue arose when a foreign pharmaceutical company filed a preliminary injunction application against a Greek pharmaceutical company, which manufactured a pharmaceutical solution for export abroad, claiming infringement of its patented manufacturing process.

The defendant argued that its manufacturing process was different highlighting, inter alia, a difference in the order of the steps performed for the preparation of its pharmaceutical solution compared to the patented process.

The Court was not convinced by the defendant's line of defence. After providing an analysis of the doctrine of equivalents theory, the judgment found that both processes employ the same material and that the steps performed are the same. The judge added that the main features of the invention were present in both processes and that the change in the order of the process steps by the defendant had no significance for the final result.

A preliminary injunction was thus granted ordering the defendant to cease any productive activity infringing the patent, to recall the manufactured products and to provide the claimant with all information necessary to identify any parties involved in the distribution and marketing of the infringing products abroad. Furthermore the Court ordered the provisional seizure of any infringing products found in the possession of the defendant or any other party deriving rights therefrom.

A further interesting aspect of this judgment is that the products were not manufactured to be sold in Greece but were only intended to be exported for sale in foreign markets. The grant of a preliminary injunction against the manufacturer may therefore constitute an effective strategy in preventing those sales in a larger number of countries.

kilimiris.jpg

Constantinos Kilimiris


Patrinos & Kilimiris7, Hatziyianni Mexi Str.GR-11528 AthensGreeceTel: +30210 7222906, 7222050Fax: +30210 7222889info@patrinoskilimiris.comwww.patrinoskilimiris.com

more from across site and SHARED ros bottom lb

More from across our site

A strong Canadian business helped lift profits, but the IP service group's latest results underline the pressure facing its operations in Australia, New Zealand and parts of Asia
Wins in court have been key to the six-year-old firm’s growth, as one of its founders explains
The firm’s co-CEO discusses patent litigation, collaboration with overseas colleagues and the next generation of leaders
Two recent decisions demonstrate the courts’ creativity in cutting-edge IP disputes that tested their jurisdictional powers
Aditi Verma Thakur, managing partner at Aishani Partners, discusses 5 am wake-ups, working with high-performing professionals and staying calm under pressure
After more than three decades at Wilson Sonsini, Ian Edvalson explains why he moved to expand his life sciences transactional practice
While individual lateral hires and full-scale mergers remain popular options to scale a firm’s IP practice, recent activity indicates that a third option is proving successful
Lead King & Spalding trial lawyer says that while this is the first IP litigation defence victory for DoorDash, it certainly won’t be the last
As firms invest in scale, professional management and technology, trusted client relationships may become the competitive edge that cannot be automated
As UPC activity continues to drive strategic hiring and expansion, recent rulings have delivered a notable win for Samsung, and further uncertainty in the long-running GSK-Pfizer vaccine battle
Gift this article